CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMP4 Therapeutics Corporation, a biopharmaceutical company listed on Nasdaq under the ticker symbol CAMP, based in Cambridge, Massachusetts, announced today that on June 15, 2026, they granted non-qualified stock options for the purchase of a total of 39,000 shares of the company's common stock. These stock options were given to three new employees as inducements for joining the company. The goal of CAMP4 is to develop RNA-targeting therapeutics to increase gene expression, aiming to restore healthy protein levels for the treatment of various genetic diseases. This action was taken in compliance with Nasdaq Listing Rule 5635(c)(4).